Gilead Sciences: Hepatitis C and Hedge Fund Profiteers – Hedge Clippers

This is the latest from Hedge Clippers – we thought readers would enjoy the read for the info (and the humor). Gilead Sciences: Hepatitis C and Hedge Fund Profiteers by Hedge Clippers Meet The Hedge Fund Managers Cashing In On Predatory Drug Pricing Schemes from Gilead Sciences For millions of Americans infected with Hepatitis C, the inflated prices of new Hepatitis C drugs from Gilead Sciences translate into limited access and prolonged illness. The pharmaceutical giant is charging as much as $1,125 per pill and $94,500 for a course of its lifesaving treatments, forcing health care systems to limit access,…